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Abstract
Background: Acute kidney injury (AKI) is a complication of severe malaria, and rhabdomyolysis with myoglobinuria
is an uncommon cause. We report an unusual case of severe falciparum malaria with dengue coinfection
complicated by AKI due to myoglobinemia and myoglobinuria while maintaining a normal creatine kinase (CK).
Case presentation: A 49-year old Indonesian man presented with fever, chills, and rigors with generalized myalgia
and was diagnosed with falciparum malaria based on a positive blood smear. This was complicated by
rhabdomyolysis with raised serum and urine myoglobin but normal CK. Despite rapid clearance of the parasitemia
with intravenous artesunate and aggressive hydration maintaining good urine output, his myoglobinuria and
acidosis worsened, progressing to uremia requiring renal replacement therapy. High-flux hemodiafiltration
effectively cleared his serum and urine myoglobin with recovery of renal function. Further evaluation revealed
evidence of dengue coinfection and past infection with murine typhus.
Conclusion: In patients with severe falciparum malaria, the absence of raised CK alone does not exclude a
diagnosis of rhabdomyolysis. Raised serum and urine myoglobin levels could lead to AKI and should be monitored.
In the event of myoglobin-induced AKI requiring dialysis, clinicians may consider using high-flux hemodiafiltration
instead of conventional hemodialysis for more effective myoglobin removal. In Southeast Asia, potential endemic
coinfections that can also cause or worsen rhabdomyolysis, such as dengue, rickettsiosis and leptospirosis, should
be considered.
Keywords: Falciparum malaria, Rhabdomyolysis, Myoglobinuria, Acute kidney injury
Background
Acute kidney injury (AKI) is a feature of severe malaria
infection [1], and multiple mechanisms have been impli-
cated [2,3]. Among them, rhabdomyolysis is an uncom-
mon etiology with few reports in the literature [4-8].
The diagnosis is usually based on symptoms of myalgia
and high levels of serum muscular enzymes, such as cre-
atine kinase (CK) and myoglobin. Evidence of skeletal
muscle damage in falciparum malaria has been found in
both children and adults with serum CK and myoglobin
concentrations paralleling clinical severity [9-11]. Davis
et al. examined the muscle biopsies of 36 cases of falcip-
arum malaria and found parasite sequestration in skel-
etal muscle and muscle damage, along with a significant
correlation between serum CK and myoglobin levels.
Even though more than half of the patients suffered AKI
with two needing dialysis, only two patients had
hemoglobinuria with none having myoglobinuria [11]. In
another study involving 12 patients who had severe fal-
ciparum malaria (including eight cerebral malaria cases)
and elevated CK compatible with rhabdomyolysis, there
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were no cases with myoglobinuria or hemoglobinuria
[8]. Therefore, falciparum malaria complicated by
rhabdomyolysis with concomitant raised CK and myo-
globinuria is very rare with only two cases reported so
far [4,7]. However, to the best of our knowledge, there
are no cases of severe falciparum malaria with AKI re-
quiring dialysis as a result of myoglobinuria in the set-
ting of normal CK. In this report, we will detail a case
and review the significance of this finding with reference
to the selection of appropriate modalities of renal re-
placement therapy in the management of the AKI.
Case presentation
A 49-year-old Indonesian man presented with a six-day
history of fever, chills, and rigors associated with gener-
alized myalgia that was especially painful over bilateral
thighs. This was associated with two episodes of non-
bilious, non-bloody vomiting three days before admis-
sion and mild dyspnea one day earlier. He had no past
medical history, specifically no known renal disease. He
was a palm oil plantation worker and had recently trav-
eled to Tanjung Pinang in the Riau Islands two weeks
before. On admission, he was febrile at 39.3°C with a
pulse rate of 108 beats/min, but normotensive, alert, and
oriented. He was dehydrated and jaundiced but did not
demonstrate any flapping tremor or pedal edema. There
was generalized myalgia with both his thighs visibly
swollen and tender to palpation. His heart sounds were
dual, lungs were clear, and there was no hepatospleno-
megaly on abdominal examination. The neurological
examination was also normal. He did not have a rash.
Blood samples showed hemoglobin of 17.1 g/dl with
hemotocrit of 47.0%, total white blood cell count of
8,910/mm3, 8% atypical monocytosis and platelet count
of 10,000/mm3 (nadir count 6,000/mm3). A blood film
revealed Plasmodium falciparum in 4.0% of erythrocytes.
His electrolytes showed moderately severe AKI: urea,
34.2 mmol/l; potassium, 4.4 mmol/l; sodium, 128 mmol/
l; creatinine, 550 μmol/l; bicarbonate, 17.1 mmol/l; and
glucose, 6.1 mmol/l. His liver function test showed
hyperbilirubinaemia of 161 μmol/l and transaminitis
with serum ALT 122 U/l, AST 124 U/l, LDH 1,073 U/l,
alkaline phosphatase 215 U/l, and albumin 33 g/l. Serum
CK was normal at 99 U/l, but aldolase and myoglobin
were raised at 17.5 U/l and 138 μg/l (normal 27.8–
55.6 μg/l) respectively. Urine analysis revealed myoglobi-
nuria of 194 μg/l (normal <21 μg/l).
A diagnosis of severe falciparum malaria with rhabdo-
myolysis and AKI was made, and the patient was treated
with intravenous artesunate at 2.4 mg/kg of body weight
at 0, 12, and 24 hours, and then once daily for a total of
seven days. Concurrent therapy included oral meflo-
quine 750 mg at 0 hours and 500 mg at 12 hours
and intravenous ceftriaxone 2 g once daily. Despite
aggressive hydration maintaining good urine output and
clearance of parasitemia, the creatinine and urea wor-
sened to 686 μmol/l and 45.5 mmol/l, respectively, on
day four. The patient remained acidotic with a bicarbon-
ate nadir of 12.9 mmol/l. His myoglobinuria peaked at
451 μg/l, while serum CK remained normal. Alternative
etiologies of rhabdomyolysis were excluded with nega-
tive Mycoplasma pneumoniae PCR, Chlamydia pneumo-
niae PCR, Leptospira IgM, and Orientia tsutsugamushi
IgG. Rickettsia typhi IgG returned positive at a titre of
1:256, and the patient was given seven days of doxycyc-
line at 100 mg twice daily. However, no rising titre was
detected on the convalescent sample. The dengue IgM
had a weak positive result on admission and showed a
qualitative rise in titre on paired sera, but was negative
for the dengue NS1 antigen, suggesting a possible den-
gue coinfection. Despite the severe thrombocytopenia,
he did not have any bleeding tendencies. He underwent
renal replacement therapy via hemodiafiltration from
days 5 to 10 of admission. Serum myoglobin and urine
myoglobin levels improved (See Figure 1), and he was
discharged well back to Indonesia with a creatinine level
of 201 μmol/l.
Discussion
The pathogenesis of AKI in severe malaria is multifac-
torial, and these factors include various inflammatory
mediators, intravascular hemolysis and coagulation,
hypovolemia from dehydration, hyperparasitemia, and
immune complexes, among others [3]. Rhabdomyolysis
is a recognized but uncommon cause [4-8]. Miller et al.
observed 58 African children with falciparum malaria
and found raised CK and myoglobin in 28% and 45%, re-
spectively, at the time of their admission. There was a
significant correlation between CK and myoglobin levels
and also the severity of the illness as measured by
neurological status. AKI, the most common and serious
sequela of muscle damage, was however absent in this
age group [9]. Earlier reports involving adults with se-
vere malaria also demonstrated poor correlation between
raised serum CK and renal dysfunction. Skeletal muscle
necrosis severe enough to cause myoglobinuria and AKI
is actually very rare, probably because serum concentra-
tions beyond 15,000 ng/mL are required before myoglo-
bin becomes detectable in urine [12]. De Silva et al. and
Sinniah et al. separately reported two 17-year-old boys
with severe falciparum malaria complicated by oliguric
AKI and myoglobinuria needing dialysis. Both cases had
documented skeletal muscle necrosis on histopathology
and raised CK on biochemistry. The latter also had a
renal biopsy demonstrating renal tubules with myoglo-
bin casts in the lumen and foci of interstitial inflamma-
tory cells, including macrophages and T lymphocytes
[7,13].
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Our patient had non-oliguric AKI with myoglobine-
mia, myoglobinuria while maintaining a normal serum
CK. We are unable to explain why the CK had remained
normal in the setting of rhabdomyolysis since CK levels
are the most sensitive indicator of myocyte injury in
rhabdomyolysis [14]. Nevertheless, rhabdomyolysis with
elevated myoglobin without raised CK has been reported
in patients with Duchenne muscular dystrophy and ma-
lignant hypertension [15]. Myoglobin-induced renal
vasoconstriction, direct nephrotoxicity, and sequestered
intravascular parasitized erythrocytes in the renal micro-
vasculature probably caused the AKI. Rowland et al. had
suggested in the 1970s that the nephrotoxic potential of
myoglobin would be enhanced by hypovolaemia,
hypotension, fever, and acidosis, all of which may occur
in severe malaria [16].
Myoglobin is a 17.8-kDa iron- and oxygen-binding
protein found in muscle tissues. It is freely filtered by
the glomerulus and, after endocytosis occurs, enters the
tubules, where it is metabolized. When the renal thresh-
old is exceeded, it is visible as reddish-brown urine.
Myoglobin is both directly and indirectly toxic to the
kidneys, and its removal from the renal circulation is
paramount in managing AKI [17]. Earlier attempts to re-
move myoglobin using plasma exchange met with little
success [18,19], as did conventional hemodialysis filters,
due to the large molecular mass of myoglobin [17,20]. It
has been shown that rapid and effective removal of myo-
globin can be achieved via continuous venovenous
hemofiltration or hemodiafiltration through the use of
super high-flux filters and high volumes of ultrafiltration
[21-24]. Naka et al. reported a case of serotonin syn-
drome complicated by severe rhabdomyolysis and oli-
guric AKI in which super high-flux hemofiltration was
able to achieve greater clearance of myoglobin than con-
ventional hemodialysis [22]. Hutchison et al. subse-
quently reported two patients with rhabdomyolysis and
AKI in which hemodialysis with a super high-flux dialy-
zer cleared nearly 60% of the serum myoglobin with a
single dialysis treatment [23]. These observations have
been supported by a very recent case series involving six
patients [24]. Based on the evidence, super high-flux
hemofiltration appears to be a more appropriate dialysis
modality for managing myoglobin-induced AKI. In our
case, the patient underwent high-flux hemodiafiltration
(Fresenius ARrT Plus) and achieved significant myoglo-
bin clearance, as reflected in the rapid decline of serum
and urine myoglobin levels that paralleled the recovery
of his renal function. Our case report therefore high-
lights the importance of ascertaining the predominant
cause of AKI in severe malaria, which has an impact on
the choice of dialysis.
Rhabdomyolysis has been associated with other infec-
tious diseases, and these should be actively diagnosed
and treated as potential coinfections in patients with
malaria and rhabdomyolysis. Our patient did not have
upper respiratory tract symptoms to suggest influenza
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Figure 1 Serum and urine biochemistry changes from time of admission in relation to high-flux hemodiafiltration.
Yong et al. BMC Infectious Diseases 2012, 12:364 Page 3 of 5
http://www.biomedcentral.com/1471-2334/12/364
and chlamydia pneumonia. The Thais had reported no
uncommon dual infections of falciparum malaria with
scrub typhus (15%), murine typhus (23.2%) and lepto-
spirosis (7.7%) [25], all of which could cause rhabdo-
myolysis. Our patient had negative serology for acute
leptospirosis and a non-rising positive paired sera titre
to Rickettsia typhi, suggesting prior murine typhus infec-
tion. This is unsurprising given his work exposure to
rodents in the oil palm plantation.
Similarly, dengue infection is endemic in Southeast
Asia with frequent cyclical epidemics [26], and dengue
shock syndrome could certainly contribute to, if not
cause, AKI. Malaria and dengue infection share many
similar clinical findings, and a delayed diagnosis of either
in a patient with coinfection may lead to fatal complica-
tions [27,28]. In a recent study regarding diagnostic
techniques and management of dengue and malaria
coinfection, all patients with dual infections presented
with prolonged fever of more than seven days, myalgia,
bleeding manifestations, rash, and anemia [29]. More-
over, according to Vasconcelos et al., the continuous
fever caused by arboviral infection can mask the periodic
fever associated with malarial parasites [30]. Although
coinfections are uncommon, the diagnosis of one should
not rule out testing for the other [25,31,32]. In French
Guiana, 4.3% of 1,723 consecutive febrile patients pre-
senting to the Emergency Department over a one-year
period had malaria and dengue coinfection [31]. Our pa-
tient, who had fever, severe thrombocytopenia, atypical
monocytosis, a positive dengue IgM and a qualitative
rise in titre on paired sera probably had a dengue coin-
fection. The occurrence of severe thrombocytopenia
(less than 5,000/mm3) supports the concomitant pres-
ence of dengue coinfection as it is uncommon in falcip-
arum malaria, occuring in less than 2% in one series
[33]. This reinforces the importance that patients with
prolonged fever, myalgia, and thrombocytopenia should
be evaluated for both malaria and dengue infection.
Conclusion
In patients with severe falciparum malaria complicated
by AKI, it is important to consider rhabdomyolysis as a
contributing aetiology. The absence of raised serum CK
alone does not exclude a diagnosis of rhabdomyolysis.
Raised serum and urine myoglobin levels could lead to
AKI and should be monitored. In the event of
myoglobin-induced AKI requiring dialysis, clinicians
may consider using high-flux hemodiafiltration instead
of conventional hemodialysis for more effective myoglo-
bin removal. In Southeast Asia, potential endemic coin-
fections that can also cause rhabdomyolysis, such as
dengue, rickettsiosis, and leptospirosis, should be ac-
tively screened for and managed.
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